During the past decade, Tulane Cancer Center Office of Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 29 clinical trials were completed, i.e. on average, 1450% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tulane Cancer Center Office of Clinical Research" #1 sponsor was "Children's Oncology Group" with 14 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane Cancer Center Office of Clinical Research" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Tulane Cancer Center Office of Clinical Research" are "Leukemia" (9 trials), "Prostate Cancer" (6 trials), "Breast Cancer" (4 trials), "Lung Cancer" (4 trials) and "Brain Tumor" (3 trials). Many other conditions were trialed in "Tulane Cancer Center Office of Clinical Research" in a lesser frequency.

Most popular intervention types in "Tulane Cancer Center Office of Clinical Research" are "Drug" (33 trials), "Radiation" (14 trials), "Other" (13 trials), "Biological" (10 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "cytarabine" (6 trials), "etoposide" (6 trials), "radiation therapy" (6 trials) and "doxorubicin hydrochloride" (5 trials). Other intervention names were less common.

The vast majority of trials in "Tulane Cancer Center Office of Clinical Research" are 38 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Tulane Cancer Center Office of Clinical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Tulane Cancer Center Office of Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane Cancer Center Office of Clinical Research, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".